Description
TIRZEPATIDE 30MG
30mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
Tirzepatide 30mg is an experimental peptide acting as a dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide-1 (GLP-1) receptors. Within experimental protocols, this molecule is studied for its unique synergistic action on glucose metabolism, insulin sensitivity, and weight regulation. Explore our full range of Research Peptides.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | Tirzepatide 30mg |
| Sequence | Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813.45 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 30 mg per vial |
| Storage | -20°C (Dry) / 2–8°C (Reconstituted) |
| Grade | Laboratory Research Grade |
Research Application Areas
- Dual GIP/GLP-1 Agonism: Study of the synergy between both hormones on insulin secretion and glucagon suppression.
- Insulin Sensitivity: Research on improving glucose utilization by peripheral tissues (muscle and liver).
- Lipidemia and Adipose Tissue: Analysis of the impact on lipid metabolism and the reduction of ectopic fat.
- Appetite Regulation: Study of the central satiety mechanisms induced by the simultaneous activation of hormonal pathways.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
